Structure error sinks NIH-MIT-SNU peptide paper

CHBIOL_21_9.c1.inddA mistake in structure identification has sunk a paper by researchers at the NIH, MIT, and Seoul National University in the Cell Press journal Chemistry and Biology.

Here’s the notice for “Peptide-Based Inhibitors of Plk1 Polo-box Domain Containing Mono-anionic Phosphothreonine Esters and Their Pivaloyloxymethyl Prodrugs”: Continue reading Structure error sinks NIH-MIT-SNU peptide paper

Scientist sues PubPeer commenters, subpoenas site for names

Fazlul Sarkar, via Wayne State
Fazlul Sarkar, via Wayne State

Last month, we reported that a Wayne State University cancer researcher had threatened legal action involving post-publication peer review site PubPeer, claiming that he had lost a job offer from the University of Mississippi because of comments on the site.

Fazlul Sarkar — who has received $12.8 million in NIH funding and has been an investigator on five clinical trials — has now filed suit against PubPeer’s anonymous commenters, and has demanded that PubPeer release their names and identifying information. The complaint, filed by attorney Nicholas Roumel in Michigan’s Wayne County Circuit Court and which we’ve made available here, details more of the history of the case and of course describes the legal strategy, which we’ll describe below. Continue reading Scientist sues PubPeer commenters, subpoenas site for names

Dr. Oz: Following green coffee bean diet retraction, site scrubbed, “further study is needed”

green coffee beanOn Monday, we were first to report that a study of green coffee bean extract for weight loss touted on the Dr. Oz Show had been retracted.

That story has been widely picked up by the media, including The Washington Post, which yesterday reported that the show had posted a statement about the development: Continue reading Dr. Oz: Following green coffee bean diet retraction, site scrubbed, “further study is needed”

Authors retract green coffee bean diet paper touted by Dr. Oz

green coffee beanTwo authors of a 2012 paper sponsored by a company that made grand claims about green coffee bean extract’s abilities to help people lose weight have retracted it. The study was cited by The Dr. Oz Show, and last month it cost the company a $3.5 million settlement with the Feds.

Here’s the notice for “Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects,” a paper originally published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy: Continue reading Authors retract green coffee bean diet paper touted by Dr. Oz

Journal of Neuroscience still won’t explain author-initiated retractions

journal of neuroscienceThe Journal of Neuroscience hasn’t changed its policy of not explaining retractions if authors don’t want to, as this October 8 notice attests.

Here’s the notice for “Coordinated Regulation of Hepatic Energy Stores by Leptin and Hypothalamic Agouti-Related Protein:” Continue reading Journal of Neuroscience still won’t explain author-initiated retractions

Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs

JAADThe Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.

According to the notice, which is behind a paywall (for shame!), the paper appears to have overstated the number of cases the hospital itself has treated of the life-threatening condition: Continue reading Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs

Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts

Domnez_Gizem
Gizem Donmez, via Tufts

Gizem Donmez, a neuroscientist who has retracted two papers from Cell and the Journal of Biological Chemistry, is no longer in her position at Tufts University, Retraction Watch has learned.

A Tufts spokesperson confirmed the news for us yesterday: Continue reading Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts

How meta: Paper on errors retracted for “too many stupid mistakes”

Measurement-in-Physical-Education-and-Exercise-ScienceA paper published in Measurement in Physical Education and Exercise Science has been retracted for statistical and typographical mistakes.

Here’s the notice for “Comparing Measurement Error Between Two Different Methods of Measurement of Various Magnitudes”: Continue reading How meta: Paper on errors retracted for “too many stupid mistakes”

Yet another study of widely touted cancer “cure” retracted

cancer immunology immunotherapyA third study of GcMAF, a protein being used to treat a variety of conditions from AIDS to autism to cancer, all without the blessing of health agencies, has been retracted.

Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Continue reading Yet another study of widely touted cancer “cure” retracted

U. Illinois chancellor earns mega-correction for duplicate publication

Phyllis Wise, from University of Illinois
Phyllis Wise, via University of Illinois

Phyllis Wise, the chancellor of the University of Illinois and an obstetrics researcher, has called for a massive correction of a 2006 paper in Neuroscience for work she appears to have tried to pass off as having been previously unpublished — but which wasn’t.

The article, “Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models,” has been cited 47 times, according to Thomson Scientific’s Web of Knowledge.

And it had caught also the attention of readers on PubPeer, who noted that: Continue reading U. Illinois chancellor earns mega-correction for duplicate publication